Literature DB >> 15849973

Simvastatin over the counter.

.   

Abstract

In July 2004, simvastatin 10mg was reclassified in the UK from a Prescription-only medicine (PoM) to a Pharmacy (P) medicine and launched as Zocor Heart-Pro (Johnson & Johnson. MSD Consumer Pharmaceuticals). It is the first statin in the world to be sold without prescription. Zocor Heart-Pro is licensed to reduce the risk of a first major coronary heart disease (CHD) event in people likely to be at "moderate risk" of such problems. Here we review the rationale and process for reclassifying simvastatin 10mg as an over-the-counter product.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15849973     DOI: 10.1136/dtb.2005.43425

Source DB:  PubMed          Journal:  Drug Ther Bull        ISSN: 0012-6543


  2 in total

1.  Pharmacists' perceived integration into practice of over-the-counter simvastatin five years post reclassification.

Authors:  Vibhu Paudyal; Denise Hansford; Scott Cunningham; Derek Stewart
Journal:  Int J Clin Pharm       Date:  2012-06-28

2.  American, British and European recommendations for statins in the primary prevention of cardiovascular disease applied to British men studied prospectively.

Authors:  P McElduff; M Jaefarnezhad; P N Durrington
Journal:  Heart       Date:  2006-05-22       Impact factor: 5.994

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.